1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
2321B |
Hydrocarbon and Oxygenated Volatiles Panel, Blood |
2321FL |
Hydrocarbon and Oxygenated Volatiles Panel, Fluid |
2321TI |
Hydrocarbon and Oxygenated Volatiles Panel, Tissue |
2321U |
Hydrocarbon and Oxygenated Volatiles Panel, Urine |
2411B |
Inhalants Panel, Solvents, Blood |
2411TI |
Inhalants Panel, Solvents, Tissue |
2837B |
Methanol Poisoning Profile, Blood |
2837SP |
Methanol Poisoning Profile, Serum/Plasma |
6303B |
Firefighter Core Baseline Profile, Blood |
8103B |
Environmental Exposure Screen, Blood |
8620ME |
Barbiturates Panel (Qualitative), Meconium |
9101B |
Acepromazine Screen, Blood |
9101SP |
Acepromazine Screen, Serum/Plasma |
9101U |
Acepromazine Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |